STRIVE PHARMACEUTICALS — Bisacodyl Importer Profile
Pharmaceutical Importer · #13 buyer for Bisacodyl · $96.5K import value · 10 shipments · UNITED STATES · DGFT Verified
STRIVE PHARMACEUTICALS is the #13 importer of Bisacodyl from India with $96.5K in import value and 10 verified shipments. STRIVE PHARMACEUTICALS holds a 1.1% market share in Bisacodyl imports based in UNITED STATES. The company sources from 1 verified supplier across 7 formulations shipped to 1 country. Overall, STRIVE PHARMACEUTICALS imports 4 pharmaceutical products worth $2.4M across 3 therapeutic categories.
STRIVE PHARMACEUTICALS — Bisacodyl Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Bisacodyl to STRIVE PHARMACEUTICALS?
Verified from 10 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TRUECARE BIOMEDIX | $96.5K | 10 | 100.0% |
STRIVE PHARMACEUTICALS sources Bisacodyl from 1 verified Indian supplier based on 10 customs records. The primary supplier is TRUECARE BIOMEDIX accounting for 100.0% of imports.
How Does STRIVE PHARMACEUTICALS Compare to Nearest Bisacodyl Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | AUROBINDO PHARMA B.V., | NETHERLANDS | $119.6K | 7 | $17.1K |
| 12 | MOVIANTO UK LIMITED, | UNITED KINGDOM | $102.1K | 6 | $17.0K |
| 13 | STRIVE PHARMACEUTICALS ★ | UNITED STATES | $96.5K | 10 | $9.7K |
| 14 | ADCOCK INGRAM LIMITED. | SOUTH AFRICA | $87.5K | 8 | $10.9K |
| 15 | WIN WIN EXP IMP CO LTD,U LUN STREET | MYANMAR | $77.8K | 4 | $19.5K |
STRIVE PHARMACEUTICALS ranks #13 among 415 Bisacodyl importers from India. Average shipment value of $9.7K compared to the market average of $12.2K. The closest competitors by value are AUROBINDO PHARMA B.V., and MOVIANTO UK LIMITED,.
Where Does STRIVE PHARMACEUTICALS Import Bisacodyl To?
Destination countries from 10 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $96.5K | 10 | 100.0% |
STRIVE PHARMACEUTICALS imports Bisacodyl to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $96.5K.
What Bisacodyl Formulations Does STRIVE PHARMACEUTICALS Import?
| Formulation | Value | Shipments |
|---|---|---|
| Bisacodyl Tablets USP 5mg, OTHER DETAILSAS PER INVOICE & PL. | $28.6K | 2 |
| Bisacodyl Tablets USP 5mg Each Film Coated Tablet Contains: Bisacodyl USP 5mg Batch No.:Y0125001 To Y0125002 AS PER INV | $22.2K | 1 |
| BISACODYL TABLETS USP 5MG EACH FILM COATED TABLET CONTAINS: (OTHER DETAILS AS PER INVOICE) | $14.1K | 3 |
| BISACODYL TABLETS USP 5MG, O/D AS PER INV & PL. | $14.0K | 1 |
| BISACODYL TABLETS USP 5MG EACH FILM COATED TABLET CONTAINS:BISACODYL USP 5MG BATCH NO.: Y0123001 | $11.5K | 1 |
| Bisacodyl Tablets USP 5mg AS PER INV | $4.2K | 1 |
| BISACODYL TABLETS USP 5MG EACH FILM COATED TABLET CONTAINS BISACODYL USP 5MG BATCH NO.: Y0123002 AS PER INV | $1.9K | 1 |
STRIVE PHARMACEUTICALS imports 7 distinct Bisacodyl formulations from India. The top formulation is Bisacodyl Tablets USP 5mg, OTHER DETAILSAS PER INVOICE & PL. with 2 shipments worth $28.6K.
Regulatory Requirements: Importing Bisacodyl into United States
What STRIVE PHARMACEUTICALS and other importers must comply with to import Bisacodyl from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Bisacodyl
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Bisacodyl from India and How Much Does STRIVE PHARMACEUTICALS Import?
India exported $5.1M worth of Bisacodyl through 1,294 shipments from 240 suppliers to 108 countries, serving 415 buyers globally. STRIVE PHARMACEUTICALS imports $96.5K of this total, accounting for 1.1% of India's Bisacodyl exports with 10 shipments from UNITED STATES. This is verified from 10 customs shipment records covering 7 distinct formulations.
What Is the Average Order Value for STRIVE PHARMACEUTICALS's Bisacodyl Imports?
STRIVE PHARMACEUTICALS's average Bisacodyl order value is $9.7K per consignment, based on 10 shipments totaling $96.5K. STRIVE PHARMACEUTICALS is based in UNITED STATES and ranks #13 among all Bisacodyl importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Bisacodyl to STRIVE PHARMACEUTICALS?
STRIVE PHARMACEUTICALS sources Bisacodyl from 1 verified Indian supplier: TRUECARE BIOMEDIX ($96.5K, 100.0%). This is based on 10 customs records.
How Does STRIVE PHARMACEUTICALS Compare to Other Bisacodyl Importers?
STRIVE PHARMACEUTICALS ranks #13 among 415 Bisacodyl importers from India with a 1.1% market share. The top 3 importers are MOVIANTO UK LTD ($1.8M), MOVIANTO UK LIMITED ($815.4K), GENESIS PHARMACEUTICALS LTD ($630.8K). STRIVE PHARMACEUTICALS processed 10 shipments from UNITED STATES.
What Other Gastrointestinal Products Does STRIVE PHARMACEUTICALS Import?
STRIVE PHARMACEUTICALS also imports these gastrointestinal products. Each links to the detailed product page.
About STRIVE PHARMACEUTICALS
STRIVE PHARMACEUTICALS imports 4 products worth $2.4M. Beyond Bisacodyl, top products include Diphenhydramine, Aspirin, Docusate. View the complete STRIVE PHARMACEUTICALS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bisacodyl — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bisacodyl shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: STRIVE PHARMACEUTICALS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as STRIVE PHARMACEUTICALS's capped import value divided by total capped export value for Bisacodyl across all Indian exporters.
- 5.Verified Records: This page is backed by 10 individual customs records matching STRIVE PHARMACEUTICALS importing Bisacodyl, covering 7 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 415+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bisacodyl Import Data for STRIVE PHARMACEUTICALS
Access order-level details, pricing data, supplier connections, and competitive analysis for STRIVE PHARMACEUTICALS's Bisacodyl imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
STRIVE PHARMACEUTICALS
Full Company Profile →
4 products · $2.4M total trade · 3 categories
STRIVE PHARMACEUTICALS × Bisacodyl
Verified from customs records
Company Overview
Top Products by STRIVE PHARMACEUTICALS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for STRIVE PHARMACEUTICALS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bisacodyl. For current order-level data, contact TransData Nexus.